MEDICAL RESEARCH SERVICES: News on GILD, ADLS, TEVA, PWRM, SCLN – brought to you by: Stock-PR.com
Posted on April 13, 2010 at 15:01 PM EDT
Stock-PR Reporting FREE Daily Stock Alerts From Stock-PR.com ________________________________________ Gilead Sciences, Inc. (Nasdaq:GILD - News) announced recently that it has dosed the first patient in the Phase III clinical program evaluating its investigational fixed-dose, single-tablet “Quad” regimen of elvitegravir, cobicistat (formerly GS 9350), emtricitabine and tenofovir disoproxil fumarate. The Phase III clinical program for the Quad includes [...]
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here